1. Home
  2. WS vs NEO Comparison

WS vs NEO Comparison

Compare WS & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Steel Inc.

WS

Worthington Steel Inc.

SELL

Current Price

$39.72

Market Cap

1.9B

Sector

N/A

ML Signal

SELL

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

SELL

Current Price

$16.54

Market Cap

2.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
WS
NEO
Founded
1955
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
WS
NEO
Price
$39.72
$16.54
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
★ $21.85
AVG Volume (30 Days)
437.3K
★ 2.3M
Earning Date
10-06-2026
10-28-2026
Dividend Yield
★ 1.63%
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $3,443,800,000.00
N/A
Revenue This Year
$11.55
$10.71
Revenue Next Year
$0.38
$9.96
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 11.33
N/A
52 Week Low
$27.22
$7.07
52 Week High
$49.17
$20.15

Technical Indicators

Market Signals
Indicator
WS
NEO
Relative Strength Index (RSI) 61.42 43.04
Support Level $38.01 $15.57
Resistance Level $39.42 $16.92
Average True Range (ATR) 1.92 0.98
MACD 0.34 -0.18
Stochastic Oscillator 80.29 23.00

Price Performance

Historical Comparison
WS
NEO

About WS Worthington Steel Inc.

Worthington Steel Inc is a value-added metals processors with the ability to provide a diversified products and services that span a variety of end markets. It is a value-added processor of carbon flat-rolled steel and a producer of laser welded solutions and electrical steel laminations. It is one of the independent intermediate processors of carbon flat-rolled steel in the U.S. It occupy a niche in the steel industry by focusing on products requiring exact specifications. The company has one operating and reportable segment. It has presence in United States, Canada, Mexico, and Rest of world. The company has majority of sales from United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: